Jun. 22 at 11:56 AM
$SCLX $SRNE Another day another Therapeutic getting bought. One of these days....Abbvie to Acquire Apogee Therapeutics
$10.9 BILLION
https://finance.yahoo.com/healthcare/articles/abbvie-acquire-apogee-therapeutics-deepening-110000704.html
"Apogee's lead asset, zumilokibart (APG777), is a late-stage, half-life extended monoclonal
antibody targeting IL-13, in development for patients with atopic dermatitis"